EBV(+) DLBCL demonstrated greater hypermethylation across all probe sets compared to EBV(−) tumors, with enrichment of hypermethylated genes involved in tumor-suppressive pathways such as P53 feedback loops and TGF-beta signaling. The gene discussed is TP53; the disease is neoplasm.